The survey on cellular and engineered tissue therapies in Europe in 2009.
about
The EBMT activity survey: 1990-2010Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application.Hematopoietic SCT in Europe: data and trends in 2011.Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-DE-based quantitative proteomics.The survey on cellular and engineered tissue therapies in Europe in 2012.The survey on cellular and engineered tissue therapies in Europe in 2011.Burn patient care lost in good manufacturing practices?Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases.Perspective on the evolution of cell-based bone tissue engineering strategies.Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors.Recent advances and current state of immunotherapy in systemic lupus erythematosus.Progenitor cell therapy for sacral pressure sore: a pilot study with a novel human chronic wound model.Quantitative Validation of the Presto Blue Metabolic Assay for Online Monitoring of Cell Proliferation in a 3D Perfusion Bioreactor System.Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media.Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.Correcting Nasojugal Groove with Autologous Cultured Fibroblast Injection: A Pilot Study.Human periosteal-derived cell expansion in a perfusion bioreactor system: proliferation, differentiation and extracellular matrix formation.
P2860
Q28265604-8CFFE301-257C-4C5E-8160-F4278831810BQ30529826-C90B0185-A472-4C1C-B294-CE908C1E5126Q30616418-F24340D9-7A23-4FA7-9CE4-55DE142A87EBQ34391664-D5903063-BA2F-4E74-9413-E69894B37A4AQ34938449-22E02578-B37A-4CEB-9740-6EDCF6C72690Q37587989-A498B709-CF77-427A-888C-B567D24DEA09Q37618860-EA108D67-1450-4559-9E21-FD611B4EE505Q37987428-B61D2CE3-D7AD-45F2-A7A2-1AB3222287C7Q38026457-BF278DF3-F3D9-4CF9-ABBE-BA332FF54B17Q38198130-9A325EEF-0036-4049-A490-54D493C55DF8Q38794663-4F1D1B78-5D25-452E-BD47-ED732C770544Q40624030-460253C2-ADA8-4DDE-A66D-0B66ACAB6201Q41021346-1BF45CD7-BB7D-4CA1-AA87-ED194FA22D40Q41655945-A38BCB5D-DD15-48DE-9AFC-60AFF6CB6657Q44297451-822FFD3B-29E5-4B57-AD42-721BD28CA465Q47155255-C7F9EDEB-77B0-43AC-A334-747A3ECEBE83Q48353250-73C69E9C-E927-4406-93FF-44CD2A44C55AQ53023080-F1571E69-89E9-4677-B2E1-8C97D9E6E754
P2860
The survey on cellular and engineered tissue therapies in Europe in 2009.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The survey on cellular and engineered tissue therapies in Europe in 2009.
@ast
The survey on cellular and engineered tissue therapies in Europe in 2009.
@en
type
label
The survey on cellular and engineered tissue therapies in Europe in 2009.
@ast
The survey on cellular and engineered tissue therapies in Europe in 2009.
@en
prefLabel
The survey on cellular and engineered tissue therapies in Europe in 2009.
@ast
The survey on cellular and engineered tissue therapies in Europe in 2009.
@en
P2093
P2860
P1476
The survey on cellular and engineered tissue therapies in Europe in 2009.
@en
P2093
Alan Tyndall
Chiara Bocelli-Tyndall
Helen Baldomero
Ineke Slaper-Cortenbach
Ivan Martin
Jakob Passweg
P2860
P304
P356
10.1089/TEN.TEA.2011.0131
P577
2011-09-01T00:00:00Z